Oncology Clinical Trials
Learn about our patient-centered research studies designed to advance future treatment options for patients with cancer.
Oncology Research Studies
Oncology Clinical Trials for Cancer Treatment Advancement
A cancer diagnosis can bring uncertainty, difficult choices, and questions about the future. While today’s treatments have helped many patients, there is still a need for research that may lead to better options for different types of cancer.
At Zillan Clinical Research, we conduct oncology research studies to help advance the future of cancer care. If you have been diagnosed with cancer, you may be eligible to participate in a clinical trial evaluating potential new treatments under the guidance of experienced healthcare professionals. Explore our ongoing clinical trials for cancer to learn more.
Do you want to contribute to research that may improve early detection of colorectal cancer?
Colorectal cancer is one of the most common cancers, but it is often highly treatable when detected early. This clinical trial is studying a new blood-based screening test to see how well it can identify signs of colorectal cancer and advanced precancerous conditions in people at average risk. The goal is to compare results from a simple blood sample with standard colonoscopy findings to better understand its accuracy and potential role in future screening.
By joining this study, you can contribute to important research focused on improving how colorectal cancer is detected in everyday healthcare. Your participation may help researchers develop easier, less invasive screening methods that support earlier diagnosis and better prevention for future patients.
Study Information
Age Range
40 Years and Older
Gender
All genders
Condition
Colorectal Cancer Screening / Average Risk Population
Status
Recruiting
Study Type
Observational Study
Interested in participating? Contact our team for more information.
Could You Help Advance Research in Hereditary Cancer Prevention?
Hereditary genetic factors can increase the risk of developing certain cancers, including breast, ovarian, colorectal, pancreatic, and other cancer types. Our clinical trial is evaluating how genetic testing may help identify individuals at increased cancer risk and support earlier detection and preventive care strategies.
By participating in this research study, you can help researchers better understand the real-world impact of hereditary cancer genomic testing while contributing to efforts that may improve cancer prevention and screening for future generations.
Study Information
Age Range
65 Years and Older
Gender
All genders
Condition
Hereditary Cancer Risk Assessment
Status
Recruiting
Study Type
Observational Study
Interested in participating? Contact our team for more information.